211029-67-3

Basic information

• Product Name: (3-IODO-PYRIDIN-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER
• Synonyms: TERT-BUTYL 3-IODO-4-PYRIDINYLCARBAMATE;(3-IODO-PYRIDIN-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER;4-(Boc-amino)-3-iodopyridine, 96%;4-(Boc-amino)-3-iodopyridine 96%;N-Boc-4-amino-3-iodopyridine;Carbamic acid, (3-iodo-4-pyridinyl)-, 1,1-dimethylethyl ester (9CI);tert-butyl 3-iodopyridin-4-ylcarbaMate;(3-Iodopyridin-4-yl)carbamic acid 1,1-dimethylethyl ester
• CAS NO: 211029-67-3
• Molecular Formula: C₁₀H₁₃IN₂O₂
• Molecular Weight: 320.13
• Product Categories: Pyridines;Heterocycle-Pyridine series;CMLLYL
• Mol File: 211029-67-3.mol

Chemical Properties

• Melting Point: 79-83°C
• Boiling Point: 313.2 °C at 760 mmHg
• Flash Point: 143.2 °C
• Appearance: /
• Density: 1.652g/cm³
• Vapor Pressure: 0.000503mmHg at 25°C
• Refractive Index: 1.609
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 11.85±0.70(Predicted)
• Sensitive: Light Sensitive
• CAS DataBase Reference: (3-IODO-PYRIDIN-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: (3-IODO-PYRIDIN-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER(211029-67-3)
• EPA Substance Registry System: (3-IODO-PYRIDIN-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER(211029-67-3)

Safety Data

• Hazardous Substances Data: 211029-67-3(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research:
(3-IODO-PYRIDIN-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER is used as a research compound for its potential biological activity, which includes antifungal and antibacterial properties. This makes it a promising candidate for the development of new pharmaceuticals.
Used in Organic Synthesis:
(3-IODO-PYRIDIN-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER is used as a building block for the synthesis of more complex organic molecules, contributing to the advancement of chemical research and the creation of novel compounds.

InChI:InChI=1/C10H13IN2O2/c1-10(2,3)15-9(14)13-8-4-5-12-6-7(8)11/h4-6H,1-3H3,(H,12,13,14)

Downstream Products

• 211029-69-5 (3-Ethynyl-pyridin-4-yl)-carbamic acid tert-butyl ester 
• 1210045-52-5 C₂₁H₂₄N₂O₂ 
• 211029-77-5 tert-butyl 2-methyl-1H-pyrrolo[3,2-c]pyridine-1-carboxylate 
• 1260092-25-8 {3-[6-(5-fluoro-2-methoxyphenyl)-4-hydroxy-6-methyl-4-trifluoromethylhept-1-ynyl]pyridin-4-yl}carbamic acid tert-butyl ester 
• 98400-69-2 N-(4-pyridyl) t-butyl carbamate 
• 871327-75-2 [3-(4-chloro-phenylsulfonyl)-2-methyl-5-oxy-pyrrolo[3,2-c]pyridin-1-yl]-acetic acid ethyl ester 
• 871327-73-0 [3-(4-chloro-phenylsulfonyl)-2-methyl-pyrrolo[3,2-c]pyridin-1-yl]-acetic acid ethyl ester 
• 871327-71-8 [3-(4-chloro-phenylsulfanyl)-2-methyl-pyrrolo[3,2-c]pyridin-1-yl]-acetic acid ethyl ester 
• 871327-70-7 3-(4-chloro-phenylsulfanyl)-2-methyl-1H-pyrrolo[3,2-c]pyridine 

Relevant articles and documents

1,1,1-TRIFLUORO-4-PHENYL-4-METHYL-2-(1H-PYRROLO

Compounds of Formula (IA), IB), IC), and (ID) wherein R1, R2, R3, R4, R5, and R6 are as respectively defined herein for Formula (IA), (IB), (IC), and (ID), or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.